Cagrilintide/semaglutide
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
Novo Nordisk · Phase 3 · Completed · Enrollment 300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| CagriSema Dose 1 | Obesity or overweight | n/r | 60 | n/r | n/r |
| Placebo Dose 1 | Obesity or overweight | n/r | 60 | n/r | n/r |
| CagriSema Dose 2 | Obesity or overweight | n/r | 60 | n/r | n/r |
| Placebo Dose 2 | Obesity or overweight | n/r | 60 | n/r | n/r |